Moreover, we found that GBS disability scores in GBS patients with both low sRAGE and high HMGB1 levels were significantly higher than in all other patient groups studied (p = 0.006, Fig. 5A). The gene discussed is HMGB1; the disease is Guillain-Barre syndrome.